Default: Journal of Viral Hepatitis

ISSN: 1352-0504

Journal Home

Journal Guideline

Journal of Viral Hepatitis Q2 Unclaimed

Wiley-Blackwell Publishing Ltd United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of Viral Hepatitis is a journal indexed in SJR in Infectious Diseases and Virology with an H index of 107. It has a price of 3350 €. It has an SJR impact factor of 0,829 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,829.

Journal of Viral Hepatitis focuses its scope in these topics and keywords: hepatitis, chronic, virus, infection, men, patients, treatment, therapy, sex, data, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Price

3350 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Journal of Viral Hepatitis

0,829

SJR Impact factor

107

H Index

123

Total Docs (Last Year)

577

Total Docs (3 years)

4356

Total Refs

1446

Total Cites (3 years)

533

Citable Docs (3 years)

2.37

Cites/Doc (2 years)

35.41

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


hepatitis, chronic, virus, infection, men, patients, treatment, therapy, sex, data, psychosocial, response, risk, analysischanges, ?, characteristics, developing, alaskadisparate, alphab, antibodies, combination, cognitive, clearance, carcinoma, burden, background,



Best articles by citations

Hepatitis C antibody detection in dried blood spots

View more

Rebuttal to letters by Buti and Esteban, and Jacobsen and McHutchison

View more

Reversible myopathy during successful treatment with pegylated interferon and ribavirin for acute hepatitis C

View more

Fas-mediated hepatocyte apoptosis is increased by hepatitis C virus infection and alcohol consumption, and may be associated with hepatic fibrosis: mechanisms of liver cell injury in chronic hepatitis C virus infection

View more

Preoperative serum levels of wild-type and hepatitis B e antigen-negative hepatitis B virus (HBV) and graft infection after liver transplantation for HBV-related hepatocellular carcinoma

View more

Health care, treatment patterns and cost of services for patients infected with chronic hepatitis C virus in a large insured New England population

View more

High hepatitis B virus (HBV) DNA viral load is an important risk factor for HBV reactivation in breast cancer patients undergoing cytotoxic chemotherapy

View more

Should we test hepatitis C virus genotype and viraemia level in patients with chronic hepatitis C?

View more

Inhibition of hepatitis B virus by retroviral vectors expressing antisense RNA

View more

Importance of age in chronic hepatitis C virus infection

View more

Predicted secondary structure of the hepatitis G virus and GB virus-A 5' untranslated regions consistent with an internal ribosome entry site

View more

Human leucocyte interferon-alpha in chronic hepatitis C resistant to recombinant or lymphoblastoid interferon-alpha: a randomized controlled trial

View more
SHOW MORE ARTICLES

Increased effective immunogenicity to high-dose and short-interval hepatitis B virus vaccination in individuals with chronic hepatitis without cirrhosis

View more

Response to Article by Formann et al. (2003)

View more

Randomized, placebo-controlled, double-blind trial with interferon-alpha with and without amantadine sulphate in primary interferon-alpha nonresponders with chronic hepatitis C

View more

Consensus interferon: a novel interferon for the treatment of hepatitis C

View more

An outbreak of enterically transmitted non-A, non-E viral hepatitis

View more

Hepatitis C virus infection and related chronic liver disease in a resident elderly population: the Silea study

View more

Exposure to hepatitis A virus among blood donors, injecting drug users and prison entrants in Victoria

View more

Prolonged therapy of chronic hepatitis C with ribavirin

View more

Secondary structure and hybridization accessibility of the hepatitis C virus negative strand RNA 5'-terminus

View more

Epidemiological study of viral hepatitis types A, B, C, D and E among Inuits in West Greenland

View more

Prolonged treatment with interferon in patients with histologically mild chronic hepatitis C: a decision analysis

View more

Immunogenetics of hepatitis C virus

View more

FAQS